Somatostatin Receptor Scintigraphy

What Somatostatin Receptor Scintigraphy Means in Everyday Medical Language

Somatostatin Receptor Scintigraphy (SRS), also known as an Octreotide Scan, is a medical imaging test that helps find certain types of tumors in the body. It uses a small amount of a radioactive drug called octreotide, which is similar to a natural hormone named somatostatin. This drug is injected into a vein and travels through the bloodstream. Tumor cells that have special receptors for somatostatin attract and hold onto the radioactive octreotide. A special camera detects the radiation from the drug and creates pictures showing where these tumor cells are located.

This test is often used to find neuroendocrine tumors, such as carcinoid tumors or pancreatic neuroendocrine tumors. It may also help locate certain inflammatory conditions like sarcoidosis. Because these names all refer to the same test, it’s helpful to know they mean the same thing when reading medical reports or talking with your care team.

Why the Test Can Matter in Cancer Care

Neuroendocrine tumors can sometimes be hard to find because they may be small or located in places that are difficult to see with regular imaging tests. The Octreotide Scan helps doctors locate these tumors by targeting the somatostatin receptors that many of these tumor cells have. Knowing where tumors are helps doctors plan treatment, monitor how well treatment is working, or check for tumor spread after treatment.

Because the scan highlights tumor cells with somatostatin receptors, it is especially useful for tumors like carcinoid tumors, gastrinomas, glucagonomas, and other neuroendocrine tumors. However, newer imaging tests using PET scans with different radioactive drugs are sometimes used instead, depending on availability and the specific tumor type.

What Patients Might See or Hear About Somatostatin Receptor Scintigraphy

If your doctor mentions this scan, you might hear it called by other names like Octreotide Scan or SRS. You may see these terms in your medical reports, visit notes, or educational materials. The scan involves an injection of a radioactive drug followed by imaging with a special camera, usually done over several hours or even days to get the best pictures.

Because the scan is a tool to help find tumors, seeing the term does not mean you have a specific diagnosis or that a particular treatment is planned. It is important to ask your healthcare team what the scan results mean for your personal care and what the next steps might be.

How Doctors Use Somatostatin Receptor Scintigraphy

Doctors use this scan to locate neuroendocrine tumors that have somatostatin receptors. It can help find the original tumor, check if the cancer has spread, or monitor how well treatment is working. The scan is often part of the diagnosis and staging process and may be repeated during follow-up care.

The radioactive drug used in the scan is usually labeled with indium-111 or technetium-99m, and imaging is done with a gamma camera using a technique called SPECT. Newer scans using PET imaging with different radioactive drugs are sometimes preferred for higher detail, but the Octreotide Scan remains an important tool in many settings.

Common Sources of Confusion and How to Use This Information

This test is known by several names—Somatostatin Receptor Scintigraphy, Octreotide Scan, and SRS. These all refer to the same imaging procedure. Because of this, it’s helpful to compare wording in medical reports and ask your care team how the test applies to your situation.

Seeing the term alone does not provide a diagnosis or treatment plan. It is one part of a larger medical picture. Always ask your healthcare providers to explain what the scan results mean for you personally.

Safety and Next Steps

This information is meant to help you understand what Somatostatin Receptor Scintigraphy is and why it might be used. It does not replace medical advice or decisions made by your care team. If you see this term in your medical records or hear it during visits, the best next step is to ask your doctors or nurses what it means for your diagnosis, tests, or treatment options.